GAMBATO, MARTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.231
AS - Asia 610
EU - Europa 534
SA - Sud America 5
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.384
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.225
CN - Cina 290
SG - Singapore 237
IT - Italia 199
DE - Germania 68
FI - Finlandia 68
SE - Svezia 57
VN - Vietnam 53
FR - Francia 36
GB - Regno Unito 35
RU - Federazione Russa 30
IN - India 13
IE - Irlanda 12
NL - Olanda 12
UA - Ucraina 7
JP - Giappone 6
CA - Canada 5
BR - Brasile 4
HK - Hong Kong 4
ES - Italia 3
AT - Austria 2
ET - Etiopia 2
PL - Polonia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BZ - Belize 1
EC - Ecuador 1
ID - Indonesia 1
MO - Macao, regione amministrativa speciale della Cina 1
RO - Romania 1
SI - Slovenia 1
Totale 4.384
Salva come PNG Salva come JPEG
Città #
Fairfield 509
Chandler 307
Ann Arbor 300
Woodbridge 245
Ashburn 232
Houston 216
Singapore 190
Cambridge 184
Seattle 178
Wilmington 131
Santa Clara 96
Boardman 82
Beijing 77
San Diego 77
Des Moines 67
Medford 57
Padova 57
Princeton 57
Dong Ket 53
Helsinki 44
Roxbury 37
Nanjing 27
Guangzhou 24
Shenyang 16
Dublin 12
London 12
Milan 12
Hebei 10
Falls Church 9
Munich 9
New York 9
Ogden 8
Pune 8
Hefei 7
Tianjin 7
Cagliari 6
Changsha 5
Fuzhou 5
Jinan 5
Nanchang 5
Ningbo 5
Palermo 5
Paris 5
Pisa 5
Trieste 5
Vicenza 5
Washington 5
Zhengzhou 5
Chicago 4
Hong Kong 4
Nonantola 4
Phoenix 4
Redwood City 4
Shanghai 4
Borås 3
Chiswick 3
Dolo 3
Kharkiv 3
Kunming 3
Lappeenranta 3
Lozzo Atestino 3
Naples 3
Nürnberg 3
Recife 3
Rome 3
Verona 3
Villafranca Padovana 3
Addis Ababa 2
Amsterdam 2
Bologna 2
Boston 2
Dallas 2
Frankfurt am Main 2
Fremont 2
Hounslow 2
Ichikawa 2
Kilburn 2
Majadahonda 2
Miyaharachō 2
Prescot 2
Quzhou 2
Rockville 2
Taipei 2
Taizhou 2
Toronto 2
Treviso 2
Trezzo sull'Adda 2
Venice 2
Aachen 1
Baku 1
Baoding 1
Bari 1
Belize City 1
Biassono 1
Brussels 1
Bussolengo 1
Calgary 1
Campolongo 1
Charles Town 1
Charlotte 1
Totale 3.549
Salva come PNG Salva come JPEG
Nome #
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 149
Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study 143
Meld-na and Survival Benefit In Liver Transplantation 119
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 117
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 115
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 112
Liver Transplantation In Cirrhotic Patients With Meld Score < 18: A New Prognostic Model To Predict Drop-out From the Waiting List 111
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 110
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 107
De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2008 106
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 105
Female gender in the setting of liver transplantation. 102
Model for End-Stage Liver Disease-Sodium and Survival Benefit in Liver Transplantation. 99
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 99
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 94
Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents 92
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 92
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 91
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 87
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 86
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 85
A New Allocation Model For Liver Transplantation Combining Urgency Based Prioritization With Donor-recipient Matching: A Prospective Controlled Study 84
Liver transplantation for viral hepatitis in 2015 84
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 83
Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis 82
Italian practical clinical guidelines on cholangiocarcinoma: Part II, Treatment 80
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 77
Estimation of the Harm To the Waiting List As Crucial Factor In the Selection of Patients With Hepatocellular Carcinoma For Liver Transplantation 76
A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS-CoV-2 infection 75
Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation 73
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 70
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 68
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging 67
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 65
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 64
Extending transplantation criteria for hepatocellular carcinoma 64
Management of portal hypertension severe complications 63
Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology 60
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 60
Prospective Evaluation of Long Term Cognitive and Neurological Alterations in Liver Transplanted Patients with Central Pontine (CPM) and Extrapontine Myelinolysis (EPM) 56
Host and virological features of HCV infection in liver transplant setting 56
Drug induced liver injury: from pathogenesis to liver transplantation 55
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 55
Incidence of De Novo Tumors after Liver Transplantation: Results from a Multicentric Study, Italy 1990-2009 53
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 53
Clinical implications of COVID-19 in patients with chronic liver disease and liver tumor 48
Impact of Donor-Recipient Risk Factors on Patient and Graft Survival after Liver Transplantation? A Single Centre Experience 44
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 42
Reply 41
Malnourished cirrhotic patient: what should we do? 40
Management of hepatocellular carcinoma recurrence after liver transplantation 39
Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy 39
Frailty and sarcopenia in patients with cirrhosis awaiting liver transplantation: evidence from a single-centre, prospective cohort study 38
New indications for liver transplantation 32
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 31
Impact of Recipient MELD and Na plus , Donor Age on Short Patient Survival Following Liver Transplantation 29
Invasive fungal infection before and after liver transplantation 26
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 25
Recent advances in the management of acute variceal hemorrhage 22
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 20
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 20
Chest X-ray Interpretation: Detecting Devices and Device-Related Complications 14
Efficacy of immunotherapy in hepatocellular carcinoma: Does liver disease etiology have a role? 14
Trends in liver transplantation for primary sclerosing cholangitis 13
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 13
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept 13
Evolution of Liver Transplantation Indications: Expanding Horizons 12
In‐Hospital Screening Campaign Against Hepatitis C Could Be Effective for Identifying More Patients Who Still Need Treatment 4
Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship 3
Totale 4.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.336
article - articoli 21.062
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.398
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020356 0 0 0 0 0 0 71 68 69 70 61 17
2020/2021559 32 31 38 30 35 14 29 43 77 95 41 94
2021/2022877 46 107 62 36 41 118 78 50 37 52 79 171
2022/2023613 103 72 20 76 100 81 12 39 56 3 45 6
2023/2024449 30 68 45 34 36 46 55 26 20 23 24 42
2024/2025650 5 139 96 89 199 72 50 0 0 0 0 0
Totale 4.466